Gilead Sciences CEO on delivering transformative medicines, company evolutionThe career of Gilead Sciences’ chairman and CEO Daniel O’Day has allowed him to contribute to significant medical advances for some of the world’s most challenging diseases. In 2019, after more than three decades at Roche and Genentech, O’Day took the helm at Gilead Sciences. Headquartered in Foster City, Gilead is a global company with more than 17,000 employees.
Gilead has been headquartered in Foster City for 35 years. How has the company’s time in the Bay Area benefitted the region? After becoming CEO of Gilead in 2019, you laid out a vision for transforming the company. Talk about how Gilead has evolved since then. You recently announced the development of a new research center on your campus. How will this enable future innovation?
We know that our therapies will have the greatest impact if we can help break down barriers to care. Gilead partners with multiple community-based organizations that aim to address stigma, discrimination and other factors that stand in the way of health equity. Through the Gilead Foundation, we focus on social, economic and environmental factors that impact well-being and, here in the Bay area, we support a number of organizations that focus on equity in our schools.
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
Bay Area job losses at Salesforce, Workday, Pinterest revealed in new filings - San Francisco Business TimesNew WARN filings at Autodesk, Pinterest, Salesforce and others this week demystify how many Bay Area layoffs were part of recently announced company downsizings.
더 많은 것을 읽으십시오 »
Grifols plans to cut 2,300 jobs, many in the U.S. - San Francisco Business TimesThe Barcelona-based company has said the bulk of the job cuts will come in its plasma centers but hasn't said how its plan will impact its Bay Area operations.
더 많은 것을 읽으십시오 »